The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, acting director of the FDA’s Center for Drug Evaluation and Research said in a statement. “A…
Source link
Welcome to WikipediaNews.com, your premier destination for a diverse range of news categories! Here, we bring you the latest updates and insights from various fields, including technology, culture, science, and more, all inspired by the collaborative spirit of Wikipedia. Whether you're looking for breaking news, in-depth analysis, or trending topics, we’ve got something for everyone. Stay informed and engaged with the ever-evolving world of knowledge!
wikipedianews.com
© Copyright - WikipediaNews.com
